jCyte

[hthguest @hthguest]

If you have #retinitispigmentosa and live in the US, consider to take part @j_cyte 's clinical trial. This is legit research.

[jCyte @j_cyte]

@dipak_asmips Use the contact information in the article we posted earlier. It goes directly to our clinical people.

[jCyte @j_cyte]

ICYMI update on jCyte's #retinitispigmentosa therapy, currently in a phase 2b trial. #blindness #stemcells

https://t.co/0ViG8MFHjQ

[jCyte @j_cyte]

@hthguest @CIRMnews Go ahead and email the address in the article. We are recruiting

[jCyte @j_cyte]

A quick update on what's happening with jCyte's investigational #retinitispigmentosa therapy. https://t.co/0ViG8MFHjQ
#stemcells @CIRMnews

[hthguest @hthguest]

My vision is like a badly adjusted old TV set: constant flickering overlays contrast and clarity #retinitispigmentosa #visuallyimpaired

[Paul Knoepfler @pknoepfler]

Excellent video @CIRMnews on questions to ask & key stuff to think about before getting a stem cell treatment #stemcells #stemcell https://t.co/shjLck4Z0B

[UCI Health @UCIrvineHealth]

Remembering Dr. Roger Steinert: Gavin Herbert Eye Institute founder leaves legacy of innovation, improved eye care https://t.co/lAvQcUjRUB

[jCyte @j_cyte]

@mchs85 @CABiotech Southern California

[California Biotech @CABiotech]

There is no treatment for blindness caused by retinitis pigmentosa. #CABiotech @j_cyte thinks they can change that. https://t.co/mm6DBNgfYa

[Americans for Cures @Americans4Cures]

Thanks to scientists at @UCIrvine and @j_cyte, therapies for retinitis pigmentosa are on the fast track https://t.co/xXKAtTdNEj

[jCyte @j_cyte]

@dipak_asmips No fixed timeline, but the RMAT designation should speed things up.

[jCyte @j_cyte]

@dipak_asmips It's unclear when we will get FDA approval. We have to do the clinical trials first, and we just started our phase 2b trial.

[jCyte @j_cyte]

Our #retinitispigmentosa therapy receives RMAT designation from FDA https://t.co/U3sm7jzJyu
#blindness

[jCyte @j_cyte]

jCyte receives RMAT designation from FDA - could accelerate approval of #retinitispigmentosa therapy. https://t.co/U3sm7jzJyu
#stemcells

[OphthalmologyWeb @ophthalmologywb]

New #Ophthalmology #TherapeuticRoundup featuring #SantenPharma #ReNeuron @Shireplc @j_cyte #MatiTherapeutics https://t.co/GY8LpCoHOh

[jCyte @j_cyte]

jCyte launches Phase 2b trial to study efficacy of #stemcell therapy for #retinitispigmentosa
https://t.co/P7ojZ5eNzU… #blindness @CIRMnews

[jCyte @j_cyte]

@dipak_asmips @CIRMnews Email [email protected]

[California Institute for Regenerative Medicine @CIRMnews]

.@j_cyte launches CIRM-funded #stemcell clinical trial targeting the leading cause of inherited blindness https://t.co/XYr2kMLrpV

[jCyte @j_cyte]

@hthguest @CIRMnews Can't really give you an exact schedule- everything depends on the trial results.